Volume 87, Issue 5 pp. 963-970
Valvular and Structural Heart Diseases

Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries

Taku Inohara MD, PhD

Taku Inohara MD, PhD

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kentaro Hayashida MD, PhD, FESC

Corresponding Author

Kentaro Hayashida MD, PhD, FESC

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Correspondence: Kentaro Hayashida, MD, PhD, Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: [email protected]Search for more papers by this author
Yusuke Watanabe MD

Yusuke Watanabe MD

Division of Cardiology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

Search for more papers by this author
Masanori Yamamoto MD, PhD, FESC

Masanori Yamamoto MD, PhD, FESC

Division of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Japan

Search for more papers by this author
Kensuke Takagi MD

Kensuke Takagi MD

Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan

Search for more papers by this author
Fumiaki Yashima MD

Fumiaki Yashima MD

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Search for more papers by this author
Takahide Arai MD

Takahide Arai MD

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France

Search for more papers by this author
Hideyuki Shimizu MD, PhD

Hideyuki Shimizu MD, PhD

Department of Cardiovascular Surgery, Keio University School of Medicine, Tokyo, Japan

Search for more papers by this author
Bernard Chevalier MD, FESC, FACC

Bernard Chevalier MD, FESC, FACC

Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France

Search for more papers by this author
Thierry Lefèvre MD, FESC, FSCAI

Thierry Lefèvre MD, FESC, FSCAI

Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France

Search for more papers by this author
Keiichi Fukuda MD, PhD, FACC, FESC

Keiichi Fukuda MD, PhD, FACC, FESC

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Search for more papers by this author
Marie-Claude Morice MD, FESC, FACC

Marie-Claude Morice MD, FESC, FACC

Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France

Search for more papers by this author
First published: 22 October 2015
Citations: 32

Conflict of interest: Dr. Hayashida is a proctor for transfemoral-TAVI for Edwards Lifesciences. Dr. Lefèvre is a proctor for transfemoral-TAVI for Edwards Lifesciences, and is a consultant for Symetis, Directflow and Medtronic. Dr. Chevalier is a consultant for Medtronic. The other authors report no conflict of interest.

Abstract

Backgrounds

To facilitate the learning process of transcatheter aortic valve implantation (TAVI) in Japan, unique supporting systems (e.g., on-site proctor and web-based screening systems) have been developed. Nevertheless, little is known about real-world clinical outcomes after TAVI in Japan compared with their European counterparts.

Methods

From the optimized catheter valvular intervention (OCEAN-TAVI, Japan) and the Institut Cardiovasculaire Paris Sud (Massy, France) registries, we evaluated a total of 134 and 178 patients, respectively, who underwent transfemoral TAVI during the same time period.

Results

Among the French cohort, about half of the patients (N = 81, 45.5%) were treated with the Edwards SAPIEN XT. Body surface area was significantly smaller in the Japanese cohort, although operative risks for both cohorts were almost the same. A greater percentage of patients in the Japanese cohort were implanted with 23 mm valves compared with the French cohort (73.1% vs. 23.0%, P < 0.001), reflecting the smaller annulus diameter (21.8 ± 1.6 vs. 23.8 ± 2.4 mm, P < 0.001). All-cause 30-day mortality (0% vs. 0.6%, P = 1.000) and 30-day combined safety endpoint based on the Valve Academic Research Consortium 2 (VARC2) criteria (9.7% vs. 11.2%, P = 0.713) were similar when limiting the analysis to patients treated with the Edwards SAPIEN XT.

Conclusions

Despite the unfavorable aortic anatomy of the Japanese patients, their clinical outcomes after transfemoral TAVI were excellent with the same degree of safety as in an experienced European institute. This minimized learning process achieved the use of unique support systems. © 2015 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.